Pfizer sues Metsera, Novo Nordisk
Digest more
Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating ...
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s ...
Pfizer also has set its sights on becoming a giant in oncology, and to support this, completed the acquisition of Seagen in ...
Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
Pfizer has long been a solid dividend payer, having raised its dividend annually for 16 years. Its yield is high because the ...
Vertex, Corteva, and many more will also report earnings. On the economic front, The Supreme Court will hear arguments on the ...
I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback